Bixiye
Self-Administered Oncology Agents - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Natiijooyinka Raadinta
Soo bandhiga 4071 - 4080 ee natiijooyinka 4132
Bixiye
Phenylketonuria - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Sensipar (cinacalcet) - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Thrombopoietin Receptor Agonists and Tavalisse - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Pulmonary Arterial Hypertension - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Resmetirom - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Oral Inhalers - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Growth Hormone - Commercial
Oggolaanshaha Hore
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Otezla (apremilast) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026